Risk of Myocardial Infarction in Parents of HIV-infected Individuals: A population-based Cohort Study

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Rasmussen, Line D ^a   Omland, Lars H ^b   Pedersen, Court ^a   Gerstoft, Jan ^b   Kronborg, Gitte ^c   Jensen, Janne ^d   Obel, Niels ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d KOLDING HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; INTRAVENOUS DRUG ABUSE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PARENT; POPULATION BASED CASE CONTROL STUDY; POPULATION RESEARCH; RISK ASSESSMENT; VIRUS TRANSMISSION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; TIME;

ADULT; COHORT STUDIES; DENMARK; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PARENTS; RISK ASSESSMENT; TIME FACTORS;

EID: 77953347892     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-169     Document Type: Article

References (41)

1. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Soerensen HT, Vaeth M, Obel N. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007, 146:87-95.
2. Grinspoon SK. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am J Med 2005, 118(Suppl 2):23S-8S.
3. Deeks SG. Antiretroviral treatment of HIV infected adults. BMJ 2006, 332:1489. 10.1136/bmj.332.7556.1489, 1482340, 16793811.
4. Obel N, Thomsen HF, Kronborg G, Larsen CS, Hildebrandt PR, Soerensen HT, Gerstoft J. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis 2007, 44:1625-31. 10.1086/518285, 17516408.
5. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007, 92:2506-12. 10.1210/jc.2006-2190, 2763385, 17456578.
6. Friis-Moller N, Sabin CA, Weber R, d'Arminio-Monforte A, El-Sadr WM, Resiss P, Thiebaut R, Morfeldt NL, De-Wit S, Pradier C, Calvo G, Law MG, Kirk O Phillips AN, Lundgren JD. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003, 349:1993-2003. 10.1056/NEJMoa030218, 14627784.
7. Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD. D:A:D Study Group Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 2008, 371(9622):1417-26. 10.1016/S0140-6736(08)60423-7, 2688660, 18387667, D:A:D Study Group.
8. Jousilahti P, Puska P, Vartiainen E, Pekkanen J, Tuomilehto J. Parental history of premature coronary heart disease: an independent risk factor of myocardial infarction. J Clin Epidemiol 1996, 49:497-503. 10.1016/0895-4356(95)00581-1, 8636722.
9. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 2003, 348:702-10. 10.1056/NEJMoa022048, 12594314.
10. Kwong GP, Ghani AC, Rode RA, Bartley LM, Cowling BJ, da Silvia B, Donelly CA, van Sighem AI, Cameron DW, Danner SA, de Wolf F, Anderson RM. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use. AIDS 2006, 20:1941-50. 10.1097/01.aids.0000247115.81832.a1, 16988515.
11. Holmberg SD, Moorman AC, Williamson JM, Tong TC, Ward DJ, Wood KC, Greenberg AE, Jansen RS, . HIV Outpatient Study (HOPS) Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 2002, 360:1747-8. 10.1016/S0140-6736(02)11672-2, 12480430, HIV Outpatient Study (HOPS).
12. Iloeje UH, Yuan Y, L'italien G, Mauskopf J, Holmberg SD, Moorman AC, Wood KC, Moore RD. Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med 2005, 6:37-44. 10.1111/j.1468-1293.2005.00265.x, 15670251.
13. Sabin CA, d'Arminio-Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD. Data Collection on Adverse Events of Anti-HIV Drugs Study Group Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. Clin Infect Dis 2008, 46:1101-10. 10.1086/528862, 2702541, 18461712, Data Collection on Adverse Events of Anti-HIV Drugs Study Group.
14. Saves M, Chene G, Ducimetiere P, Leport C, Le Moal G, Amouyel P, Arveiler D, Ruidavets JB, Reynes J, Bingham A, Raffi F, . French WHO MONICA Project and the APROCO (ANRS EP11) Study Group Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis 2003, 37:292-8. 10.1086/375844, 12856222, French WHO MONICA Project and the APROCO (ANRS EP11) Study Group.
15. Escaut L, Monsuez JJ, Chironi G, Merad M, Teicher E, Smadja D, Simon A, Vittecoq D. Coronary artery disease in HIV infected patients. Intensive Care Med 2003, 29:969-73.
16. Varriale P, Saravi G, Hernandez E, Carbon F. Acute myocardial infarction in patients infected with human immunodeficiency virus. Am Heart J 2004, 147:55-9. 10.1016/j.ahj.2003.07.007, 14691419.
17. Barbaro G, Di Lorenzo G, Cirelli A, Grisorio B, Lucchini A, Hazra C, Barbarini G. An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy. Clin Ther 2003, 25:2405-18. 10.1016/S0149-2918(03)80283-7, 14604740.
18. Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sorensen HT. Cohort Profile: The Danish HIV Cohort Study. Int J Epidemiol PMID: 18799495.
19. Frank L. Epidemiology. When an entire country is a cohort. Science 2000, 287:2398-9. 10.1126/science.287.5462.2398, 10766613.
20. Andersen TF, Madsen M, Jorgensen J, Mellemkjaer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999, 46:263-8.
21. Kleinbaum DG, Klein M. Competing Risk Survival Analysis. Survival Analysis: A Self-Learning Text. 2005, 391-461. New York: Springer Science+Business Media, LLC, 2.
22. Diez Roux AV, Detrano R, Jackson S, Jacobs DR, Shea S, Szklo M. Acculturation and socioeconomic position as predictors of coronary calcification in a multiethnic sample. Circulation 2005, 112:1557-65. 10.1161/CIRCULATIONAHA.104.530147, 16144996.
23. Galobardes B, Lynch JW, Smith GD. Childhood socioeconomic circumstances and cause-specific mortality in adulthood: systematic review and interpretation. Epidemiol Rev 2004, 26:7-21. 10.1093/epirev/mxh008, 15234944.
24. Burr ML, Sweetnam PM. Family size and paternal unemployment in relation to myocardial infarction. J Epidemiol Community Health 1980, 34:93-5. 10.1136/jech.34.2.93, 1052050, 7400735.
25. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003, 56:124-30. 10.1016/S0895-4356(02)00591-7, 12654406.
26. Brezinka V, Padmos I. Coronary heart disease risk factors in women. Eur Heart J 1994, 15:1571-84.
27. Kaplan RC, Kingsley LA, Sharrett AR, Li X, Lazar J, Tien PC, Mack WJ, Cohen MH, Jacobsen L, Gange SJ. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis 2007, 45:1074-81. 10.1086/521935, 17879928.
28. Smith GD, Hart C, Blane D, Hole D. Adverse socioeconomic conditions in childhood and cause specific adult mortality: prospective observational study. BMJ 1998, 316:1631-5. 28561, 9603744.
29. Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, Sax PE, Schouten JT, Smieja M, . Working Group 2 Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 2008, 118:e29-e35. 10.1161/CIRCULATIONAHA.107.189624, 18566319, Working Group 2.
30. Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O, d'Arminio-Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD, . DAD study group Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS 2003, 17:1179-93. DAD study group.
31. Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med 2007, 30:371-83. 10.1007/s10865-007-9112-9, 2570223, 17570050.
32. Cadoret RJ, Troughton E, O'Gorman TW, Heywood E. An adoption study of genetic and environmental factors in drug abuse. Arch Gen Psychiatry 1986, 43:1131-6.
33. Wood E. Gender and risk factors for initiation into injection drug use. Drug Alcohol Rev 2007, 26:333-4. 10.1080/09595230701247749, 17454023.
34. Eaton DK, Kann L, Kinchen S, Ross J, Hawkins J, Harris WA, Lowry R, McManus T, Chyen D, Shanklin S, Lim C, Grumbaum JA, Wechsler H. Youth risk behavior surveillance - United States, 2005. J Sch Health 2006, 76:353-72. 10.1111/j.1746-1561.2006.00127.x, 16918870.
35. Cadoret RJ, Yates WR, Troughton E, Woodworth G, Stewart MA. Adoption study demonstrating two genetic pathways to drug abuse. Arch Gen Psychiatry 1995, 52:42-52.
36. Donovan JE, Jessor R. Structure of problem behaviour in adolescence and young adulthood. J Consult Clin Psychol 1985, 53:890-904. 10.1037/0022-006X.53.6.890, 4086689.
37. Farrell AD, Danish SJ, Howard CW. Relationship between drug use and other problem behaviours in urban adolescents. J Consult Clin Psychol 1992, 60:705-12. 10.1037/0022-006X.60.5.705, 1401386.
38. Jessor R. Risk behavior in adolescence: a psychosocial framework for understanding and action. J Adolesc Health 1991, 12:597-605. 10.1016/1054-139X(91)90007-K, 1799569.
39. Santelli J, Carter M, Orr M, Dittus P. Trends in sexual risk behaviours, by nonsexual risk behaviour involvement, U.S. high school students, 1991-2007. J Adolesc Health 2009, 44:372-9. 10.1016/j.jadohealth.2008.08.020, 19306796.
40. Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 2003, 17:2479-86. 10.1097/00002030-200311210-00010, 14600519.
41. Deeks SG, Philips AN. HIV infection, antiretroviral treatment, aging and non-AIDS related morbidity. BMJ 2009, 338:a3172. 10.1136/bmj.a3172, 19171560.